Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Inventory (2023 - 2025)

Beta Bionics' Inventory history spans 3 years, with the latest figure at $21.7 million for Q4 2025.

  • For Q4 2025, Inventory rose 63.08% year-over-year to $21.7 million; the TTM value through Dec 2025 reached $21.7 million, up 63.08%, while the annual FY2025 figure was $21.7 million, 63.08% up from the prior year.
  • Inventory for Q4 2025 was $21.7 million at Beta Bionics, up from $20.4 million in the prior quarter.
  • Across five years, Inventory topped out at $21.7 million in Q4 2025 and bottomed at $1.2 million in Q4 2023.
  • The 3-year median for Inventory is $16.5 million (2025), against an average of $15.0 million.
  • The largest annual shift saw Inventory soared 969.88% in 2024 before it surged 63.08% in 2025.
  • A 3-year view of Inventory shows it stood at $1.2 million in 2023, then skyrocketed by 969.88% to $13.3 million in 2024, then soared by 63.08% to $21.7 million in 2025.
  • Per Business Quant, the three most recent readings for BBNX's Inventory are $21.7 million (Q4 2025), $20.4 million (Q3 2025), and $17.3 million (Q2 2025).